Final ID: Mo2136
Optimizing Outcomes in Atrial Fibrillation - Where Do We Go from Here?
Monday, 11/18/2024 , 01:30PM - 02:30PM
Abstract Poster Session
Lamicq Melissa, Buchanan Cole, Lateef Azalfa, Atteya Miriam, Houston Brian, Tedford Ryan, Wehbe Ramsey
A-band titin-truncating variant promotes the development of arrhythmia-induced cardiomyopathy in a novel genetically-engineered porcine modelLee Kwonjae, Del Rio Carlos, Mcnally Elizabeth, Pfenniger Anna, Bhatnagar Ashita, Glinton Kristofor, Burrell Amy, Ober Rebecca, Mcluckie Alicia, Bishop Brian, Rogers Christopher, Geist Gail
Chung Mina, Cantlay Catherine, Crookshanks Michael, Mchale Megan, Lovano Beth, Castel Laurie, Park Kevin, Foster Parker, Guo Lydia, Yang Lucy, Sullivan Erin, Wass Sojin, Jin Alison, Cantlay Paul, Varma Niraj, Barzilai Benico, Bruemmer Dennis, Cho Leslie, Huang Julie, Hussein Ayman, Kashyap Sangeeta, Xlaffinx Xlukex, Sun Han, Mehra Reena, Moravec Christine, Saliba Walid, Wazni Oussama, Sanders Prashanthan, Nissen Steven, Van Iterson Erik, Smith Jonathan, Van Wagoner David, Barnard John, Kim Hyun Su, Schilling Taylor, Telfer William, Lissemore Frances, Bibidakis Dimitra, Lin Cheryl
Expression of proteins encoded by putative atrial fibrillation risk genes in human left atrial appendage differs by AF stateRennison Julie, Smith Jonathan, Chung Mina, Barnard John, Van Wagoner David, Cantlay Catherine, Li Ling, Lovano Beth, Castel Laurie, Cantlay Paul, Gillinov A, Moravec Christine, Willard Belinda